Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 1775 of 3499 entries
View as:

Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00091039 Org: User:
Start: 08/31/04 End: 02/28/06 Due: 02/28/07

Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00072085 Org: User:
Start: 09/30/03 End: 07/31/06 Due: 07/31/07

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00019331 Org: User:
Start: 10/31/97 End: 05/31/07 Due: 05/31/08

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002625 Org: User:
Start: 03/31/95 End: 09/30/00 Due: 09/30/01

A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...

Phase: N/A Priority: Normal
NCT ID: NCT00923481 Org: User:
Start: 04/30/09 End: 01/31/12 Due: 01/31/13

Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00058097 Org: User:
Start: 08/31/03 End: - Due: -

Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00039104 Org: User:
Start: 04/30/02 End: - Due: -

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00243074 Org: User:
Start: 11/30/05 End: 12/31/11 Due: 12/31/12

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00112905 Org: User:
Start: 10/31/05 End: 03/31/08 Due: 03/31/09

Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00559507 Org: User:
Start: 10/31/07 End: 02/28/11 Due: 02/28/12

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT04631029 Org: User:
Start: 04/27/21 End: 07/11/23 Due: 07/11/24

Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00813423 Org: User:
Start: 02/19/10 End: 07/18/23 Due: 07/18/24

Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00126659 Org: User:
Start: 01/31/06 End: 12/31/09 Due: 12/31/10

Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01866410 Org: User:
Start: 05/20/13 End: 03/30/18 Due: 03/30/19

BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00040755 Org: User:
Start: 05/31/02 End: - Due: -

Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT04533750 Org: User:
Start: 12/20/21 End: 07/31/25 Due: 07/31/26

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

Phase: N/A Priority: Normal
NCT ID: NCT02521285 Org: User:
Start: 01/15/16 End: 03/17/26 Due: 03/17/27

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01057121 Org: User:
Start: 08/27/10 End: 08/04/14 Due: 08/04/15

A Phase II Study of UCN-01 in Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00072189 Org: User:
Start: 11/30/03 End: 03/31/10 Due: 03/31/11

Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00101088 Org: User:
Start: 04/30/05 End: - Due: -

Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT03047213 Org: User:
Start: 08/24/17 End: 11/11/25 Due: 11/11/26

Self-Affirmation and Response to Health Risk Information

Phase: N/A Priority: Normal
NCT ID: NCT01668771 Org: User:
Start: 08/11/12 End: 05/13/13 Due: 05/13/14

Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies

Phase: N/A Priority: Normal
NCT ID: NCT00427726 Org: User:
Start: 03/06/03 End: 05/20/14 Due: 05/20/15

3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00081276 Org: User:
Start: 07/31/05 End: - Due: -

A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00972309 Org: User:
Start: 05/11/09 End: 02/04/15 Due: 02/04/16